logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
Showing 1 - 20 of 128 Items
Showing 1 - 20 of 128 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Decentralising TB diagnosis and contact management: impact on detection and preventive treatment in children

Delmas V, Vasiliu A, Tchakounté Youngui B, Ssekyanzi B, Kuate Kuate A,  et al.
2025-06-27 • International Journal of Tuberculosis and Lung Disease
2025-06-27 • International Journal of Tuberculosis and Lung Disease

BACKGROUND

The ‘CaP-TB’ project enhanced paediatric TB care through decentralized services, including screening, specimen collection, chest X-rays and implement...

Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Letter
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Letter

Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes

Campbell JR, Chan ED, Anderson LF, Bonnet M, Brode SK, 
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Letter
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Letter

In reply to 'Language in tuberculosis services'

Zachariah R, Edginton ME, Srinath S
2012-06-01 • International Journal of Tuberculosis and Lung Disease
2012-06-01 • International Journal of Tuberculosis and Lung Disease
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research

Standards for clinical trials for treating TB

du Cros PAK, Greig J, Cross GB, Cousins C, Berry C,  et al.
2023-12-01 • International Journal of Tuberculosis and Lung Disease
2023-12-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
The value, speed of completion and robustness of the evidence generated by TB treatment trials could be improved by implementing standards for best practice.

METH...

Household drug-resistant TB contact tracing in Tajikistan

Rekart ML, Aung A, Cullip T, Mulanda WK, Mun L,  et al.
2023-10-01 • International Journal of Tuberculosis and Lung Disease
2023-10-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
Tajikistan has a high burden of rifampicin-resistant TB (RR-TB), with 2,700 new cases estimated for 2021 (28/100,000 population). TB is spread among household members thro...

Clinical standards for drug-susceptible TB in children and adolescents

Chiang SS, Graham SM, Schaaf HS, Marais BJ, Sant’Anna CC,  et al.
2023-08-01 • International Journal of Tuberculosis and Lung Disease
2023-08-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
These clinical standards aim to provide guidance for diagnosis, treatment, and management of drug-susceptible TB in children and adolescents.

METHODS
Fifty-tw...

Linezolid resistance in patients with drug-resistant TB

Vengurlekar D, Walker C, Mahajan R, Dalal A, Chavan VV,  et al.
2023-07-01 • International Journal of Tuberculosis and Lung Disease
2023-07-01 • International Journal of Tuberculosis and Lung Disease

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications

Rich ML, Khan UT, Zeng C, LaHood AN, Franke MF,  et al.
2023-06-01 • International Journal of Tuberculosis and Lung Disease
2023-06-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
Evidence of the effectiveness of the WHO-recommended design of longer individualized regimens for multidrug- or rifampicin-resistant TB (MDR/RR-TB) is limited.

OB...

Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

Moe S, Rekart ML, Hernandez D, Sholpan A, Ismailov A,  et al.
2023-05-01 • International Journal of Tuberculosis and Lung Disease
2023-05-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND:
Bedaquiline (BDQ) is widely used in the treatment of rifampicin-resistant TB (RR-TB). However, resistance to BDQ is now emerging. There are no standardised regimens for ...
et al.
2023-04-01 • International Journal of Tuberculosis and Lung Disease
2023-04-01 • International Journal of Tuberculosis and Lung Disease

'I didn't know so many people cared about me': support for patients who interrupt drug-resistant TB treatment

Snyman L, Venables E, Trivino Duran L, Mohr E, Azevedo VD,  et al.
2018-09-01 • International Journal of Tuberculosis and Lung Disease
2018-09-01 • International Journal of Tuberculosis and Lung Disease
SETTING
Early interventions for patients who interrupt their treatment for drug-resistant tuberculosis (DR-TB) are rarely reported and assessed. A novel, patient-centred intervention...

Outcomes from the first multidrug-resistant tuberculosis programme in Kenya

Huerga H, Bastard M, Kamene M, Wanjala S, Arnold A,  et al.
2017-03-01 • International Journal of Tuberculosis and Lung Disease
2017-03-01 • International Journal of Tuberculosis and Lung Disease
SETTING
In March 2006, the first multidrug-resistant tuberculosis (MDR-TB) treatment programme was implemented in Kenya.

OBJECTIVE
To describe patients' treatment outcom...

Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting

Cox V, De Azevedo V, Stinson K, Wilkinson LS, Rangaka MX,  et al.
2015-11-01 • International Journal of Tuberculosis and Lung Disease
2015-11-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND
The World Health Organization recommends tuberculin skin tests (TSTs) where feasible to identify individuals most likely to benefit from isoniazid preventive therapy (IPT)...

Family directly observed therapy for children with drug-resistant TB

Rekart ML, Morshed T, Mulanda WK, Klieascikova J, Sitali N,  et al.
2022-08-01 • International Journal of Tuberculosis and Lung Disease
2022-08-01 • International Journal of Tuberculosis and Lung Disease

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa

Sinanovic E, Ramma L, Vassall A, Azevedo VD, Wilkinson LS,  et al.
2015-02-01 • International Journal of Tuberculosis and Lung Disease
2015-02-01 • International Journal of Tuberculosis and Lung Disease
SETTING
The cost of multidrug-resistant tuberculosis (MDR-TB) treatment is a major barrier to treatment scale-up in South Africa.

OBJECTIVE
To estimate and compare the c...

Does One Size Fit All? Drug Resistance and Standard Treatments: Results of Six Tuberculosis Programmes in Former Soviet Countries

Bonnet MMB, Sizaire V, Kebede YYK, Janin A, Doshetov D,  et al.
2005-10-01 • International Journal of Tuberculosis and Lung Disease
2005-10-01 • International Journal of Tuberculosis and Lung Disease
SETTING: After the collapse of the Soviet Union, countries in the region faced a dramatic increase in tuberculosis cases and the emergence of drug resistance. OBJECTIVE: To discuss the r...

Reducing the Number of Sputum Samples Examined and Thresholds for Positivity: An Opportunity to Optimise Smear Microscopy

Bonnet MMB, Ramsay AR, Gagnidze L, Githui W, Guerin PJ,  et al.
2007-09-01 • International Journal of Tuberculosis and Lung Disease
2007-09-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Urban health clinic, Nairobi. OBJECTIVE: To evaluate the impact on tuberculosis (TB) case detection and laboratory workload of reducing the number of sputum smears examined and ...

Implementing Joint TB and HIV Interventions in a Rural District of Malawi: Is There a Role for an International Non-Governmental Organisation?

Zachariah R, Teck R, Harries AD, Humblet P
2004-09-01 • International Journal of Tuberculosis and Lung Disease
2004-09-01 • International Journal of Tuberculosis and Lung Disease
In a rural district in Malawi, poorly motivated health personnel, shortages of human and financial resources, weak dialogue between existing tuberculosis (TB) and human immunodeficiency ...

Population Differences in Death Rates in HIV-Positive Patients with Tuberculosis

Ciglenecki I, Glynn JR, Mwinga A, Ngwira B, Zumla A,  et al.
2007-10-01 • International Journal of Tuberculosis and Lung Disease
2007-10-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Randomised controlled clinical trial of Mycobacterium vaccae vaccination as an adjunct to anti-tuberculosis treatment in human immunodeficiency virus (HIV) positive patients wit...

Performance of FASTPlaqueTB and a modified protocol in a high HIV prevalence community in South Africa

Trollip AP, Albert H, Mole R, Marshall T, van Cutsem G,  et al.
2009-06-01 • International Journal of Tuberculosis and Lung Disease
2009-06-01 • International Journal of Tuberculosis and Lung Disease
Modifications in the FASTPlaqueTB test protocol have resulted in an increase in the analytical limits of detection. This study investigated whether the performance of a modified prototyp...

Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

Sanchez-Padilla E, Marquer C, Kalon S, Qayyum S, Hayrapetyan A,  et al.
2014-02-01 • International Journal of Tuberculosis and Lung Disease
2014-02-01 • International Journal of Tuberculosis and Lung Disease
SETTING
Armenia, a country with a high prevalence of drug-resistant tuberculosis (DR-TB).

OBJECTIVE
To identify factors related to default from DR-TB treatment in Yereva...